39.53MMarket Cap-2455P/E (TTM)
0.756High0.591Low1.69MVolume0.598Open0.598Pre Close1.13MTurnover6.01%Turnover RatioLossP/E (Static)55.50MShares1.57052wk High3.73P/B19.97MFloat Cap0.48052wk Low--Dividend TTM28.04MShs Float16.000Historical High--Div YieldTTM27.64%Amplitude0.480Historical Low0.667Avg Price1Lot Size
Icecure Medical Stock Forum
Benzinga· 3 mins ago
PRECICE study, financed by the Umberto Veronesi Foundation and the Italian Ministry of Health, is led by multidisciplinary collaborators including breast surgeons, interventional radiologists, and breast imaging and pathology specialists
PRECICE is exclusively using ProSense to treat all 233 Lu...
IceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of Health
IceCure Medical's ProSense® has been selected for the PRECICE study, a major breast cryoablation research initiative led by the European Institute of Oncology. The study, sponsored by the Umberto Veronesi Foundation and Italian Ministry of Health, will exclusively use ProSense® to treat 233 patients aged...
1 min ago
FDA Advisory Panel Votes in Favor of Icecure's Prosense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
📊⚡️📊
approval!
Comments from key stakeholders, including doctors, nurses, researchers, and breast cancer patients, are available on FDA websiteFDA Advisory Panel...
No comment yet